AGA Family of Websites: Gastro.org
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
  January 26, 2021

5 IBD updates from the 2021 Crohn’s & Colitis Congress®

Diet as complementary therapy, misconceptions around inflammatory bowel disease (IBD) drugs, when to reduce therapy and more.
Share on facebook
Share on twitter
Share on linkedin
Share on email

The IBD community came together virtually Jan. 21-24, 2021, for the annual Crohn’s & Colitis Congress®, a partnership of AGA and the Crohn’s & Colitis Foundation. Thanks to our engaged attendees and expert faculty, the meeting was a huge success! Our more than 1,400 attendees left with state-of-the-art updates to improve IBD patient care and research. Below are five of the top take-aways from the meeting, as seen on Twitter. 

Save the date: next year’s Congress will take place in Las Vegas, Jan. 20-22, 2022.

Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.

X